Lunai Bioworks Inc. - 8-K Filing

Lunai Bioworks enters into amended employment agreement with CEO David Weinstein and files for voluntary delisting from Nasdaq. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 22:17 UTC

Tickers: $LNAI

Read the full article at SEC EDGAR

Part of the story Peraso Inc. - 8-K Filing (3 articles)

More Regulatory news

Bright Mountain Media, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:25 UTC
Aptevo Therapeutics Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 22:25 UTC
MEXCO ENERGY CORP - 10-Q Filing SEC EDGAR · November 12, 2026, 22:25 UTC
Gulf Coast Ultra Deep Royalty Trust - 10-Q Filing SEC EDGAR · November 12, 2026, 22:24 UTC
ORAMED PHARMACEUTICALS INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:23 UTC
Corteva, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 22:23 UTC
Tamboran Resources Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 22:22 UTC
DROPBOX, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 22:22 UTC
Akari Therapeutics Plc - 8-K Filing SEC EDGAR · November 12, 2026, 22:21 UTC
iANTHUS CAPITAL HOLDINGS, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 22:21 UTC